2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Genital Warts: new trials by email Literature Review of Genital Warts trials Research Report on Genital Warts
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts GS-9191 ointment, GS-9191, Placebo - Genital Warts | Phase 1 | Completed | Gilead Sciences | 202 | 2007-08-01 | 2009-04-09 |
| Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) Octavalent HPV with 15 mcg IMX / AAHS, Octavalent HPV with 30 mcg IMX / AAHS, Octavalent HPV with 60 mcg IMX / AAHS - Human Papilloma Virus, Cervical Cancer | Phase 1 | Completed | Merck Sharp & Dohme LLC | 158 | 2006-04-01 | 2016-02-03 |
Condylomata Acuminata (2) · Uterine Cervical Neoplasms (1) · Vaginal Neoplasms (1) · Vulvar Neoplasms (1)
Communicable Diseases (2) · DNA Virus Infections (2) · Disease Attributes (2) · Genital Diseases (2) · Infections (2) · Papillomavirus Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Sexually Transmitted Diseases (2) · Sexually Transmitted Diseases, Viral (2) · Skin Diseases (2) · Skin Diseases, Infectious (2) · Skin Diseases, Viral (2) · Skin and Connective Tissue Diseases (2) · Tumor Virus Infections (2)
GS-9191 (1) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)
Gilead Sciences (1) · Merck Sharp & Dohme LLC (1)
United States (1)
Elsa Mondou, MD (1)